Serum concentrations of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in patients with chronic hepatitis

Scandinavian Journal of Gastroenterology

Volumn 35, Issue 11, 2000, Pages 1212-1215

  Okan, A ^a   Comlekci, A ^a   Akpinar, H ^a   Okan, I ^a   Yesil, S ^a   Tankurt, E ^a   Simsek, I ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Chronic hepatitis; Insulin like growth factor binding protein 3; Insulin like growth factor I

Indexed keywords

HUMORAL ANTIBODY; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; DISEASE COURSE; FEMALE; HUMAN; INFLAMMATION; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; VIRUS HEPATITIS;

EID: 0033637530     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655200750056718     Document Type: Article

References (18)

1. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations
2. Differential cellular synthesis of insulin-like growth factor binding protein-1 (IGFBP-1) and IGFBP-3 within human liver
3. Classification of chronic hepatitis: Diagnosis, grading and staging
4. Serum insulin-like growth factor I levels in adult diabetic patients: The effect of age
5. Report of the expert committee on the diagnosis and classification of diabetes mellitus
6. Insulin-like growth factors (IGF) in liver disease: Differential changes of IGF-I and IGF-II
7. Growth hormone, insulin-like growth factor-1, and insulin-like growth factor binding proteins 1 and 3 in chronic liver disease
8. Concentrations, release, and disposal of insulin-like growth factor (IGF)-binding proteins (IGFBP), IGF-I, and growth hormone in different vascular beds in patients with cirrhosis
9. Growth hormone-stimulated insulin-like growth factor (IGF) I and IGF-binding protein-3 in liver cirrhosis
10. Nutritional and prognostic significance of insulin-like growth factor 1 in patients with liver cirrhosis
11. Prognostic value of insulin-like growth factor I and its binding protein in patients with alcohol-induced liver disease. EMALD group
12. Insulin-like growth factor binding protein-3: A novel biomarker for the assessment of the synthetic capacity of hepatocytes in liver cirrhosis
13. Insulin-like growth factor 1 (IGF-1) in liver cirrhosis: A marker of hepatocellular dysfunction?
14. Insulin-like growth factor system abnormalities in hepatitis C-associated osteosclerosis. Potential insights into increasing bone mass in adults
15. Endocrine evaluation in patients treated with interferon-alpha for chronic hepatitis C
16. Cellular localization and regulation of gene expression for components of the insulin-like growth factor ternary binding protein complex
17. Coculture of primary rat hepatocytes and non-parenchymal cells permits expression of insulin-like growth factor binding protein-3 in vitro
18. Insulin-like growth factors and their binding proteins